DevelRx continues its medical education support for psychiatrists and other healthcare providers treating attention deficit hyperactivity disorder.

DevelRx continues its medical education support for psychiatrists and other healthcare providers treating attention deficit hyperactivity disorder.  At the invitation of Takeda Pharmaceuticals, David Heal will be presenting a lecture entitled “How can pharmacology help determine treatment choice in ADHD?” at the Dutch Paediatric Society (NVK; Nederlandse Vereniging voor Kindergeneeskunde) Virtual Meeting on Thursday December 17th, 15.30-16.00h (UK time).